This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1111/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51469005
rdf:type
wikibase:Item
schema:description
scienca artikolo 2007年學術文章 tieteellinen artikkeli 2007년 논문 επιστημονικό άρθρο artigo científico naučni članak artículu científicu 2007年學術文章 artikel ilmiah articolo scientifico wissenschaftlicher Artikel 2007年学术文章 научна статия artikulong pang-agham scientific article published in July 2007 vitskapeleg artikkel 2007年の論文 מאמר מדעי مقالة علمية نشرت في يوليو 2007 2007年學術文章 научни чланак บทความทางวิทยาศาสตร์ научни чланак 2007年学术文章 vědecký článek 2007年学术文章 wetenschappelijk artikel artigo científico 2007年学术文章 vedecký článok tudományos cikk 2007 nî lūn-bûn scientific article published in July 2007 мақолаи илмӣ vitenskapelig artikkel 2007年學術文章 article científic জুলাই ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научная статья article scientific bilimsel makale article scientifique bài báo khoa học наукова стаття, опублікована в липні 2007 artigo científico articol științific 2007年學術文章 სამეცნიერო სტატია artículo científico publicado en 2007 vetenskaplig artikel 2007年学术文章 2007年学术文章 videnskabelig artikel artykuł naukowy artikull shkencor scientific article published in July 2007 teaduslik artikkel
p:P577
wds:Q51469005-033CAC60-A91A-429F-BD87-287296C3B13B
wdt:P577
2007-07-01T00:00:00Z
p:P2860
wds:Q51469005-00A9D249-F4B4-4B87-9738-8CC78D1D31B1 wds:Q51469005-C2C89F15-7AEE-4116-8688-F529852B975E wds:Q51469005-96FF0575-50CE-460B-AD0F-DF2E830003B7 wds:Q51469005-42F8FE76-9FEE-4EA7-856C-F09B74E763C2 wds:Q51469005-13496E0C-5194-4727-B29F-825DBD93A9F7
wdt:P2860
wd:Q46458885 wd:Q29614551 wd:Q35038326 wd:Q27860882 wd:Q36283811
p:P2093
wds:Q51469005-FFC8022A-B64A-4C3E-82C2-665250480B3F wds:Q51469005-F75B24E7-E72F-4CA5-873B-4B7D7A704B2B wds:Q51469005-F3173250-75DB-4428-8A36-559024C5A033 wds:Q51469005-21EABF67-82F2-4CF6-8C89-6702137DED71 wds:Q51469005-241ED2F7-0072-4FBC-967E-D08A47E03785
wdt:P2093
Collober-Maugeais C Pecher E Cressier F Tang P Ristic S
rdfs:label
Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results. Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results.
skos:prefLabel
Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results. Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results.
schema:name
Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results. Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results.
p:P1476
wds:Q51469005-23527A62-E16B-4E9F-9B93-E3F4B4A7FED2
wdt:P1476
Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results.
p:P304
wds:Q51469005-21DF3D00-CEBC-4B3C-A9F1-E6CCDF0E581A
wdt:P304
506-511
p:P31
wds:Q51469005-4A8F74E7-D772-4F9C-BFA4-97DADAD73625
wdt:P31
wd:Q13442814
p:P921
wds:Q51469005-12896B44-7DE4-4C3C-89B5-BAEE66876FEE wds:Q51469005-9DAF974A-EC2A-4C8C-BB6A-E8F93104CEC6 wds:Q51469005-F8CB1CB7-A0D4-40D2-B835-3E3FC897F4F1
wdt:P921
wd:Q290001 wd:Q19484 wd:Q3025883
p:P698
wds:Q51469005-69043168-24F6-4819-A368-3CE00CBA0691
wdtn:P698
n12:17587393
wdt:P698
17587393
p:P1433
wds:Q51469005-A57C2416-CFF5-4411-A91A-53BDB4877E9D
wdt:P1433
wd:Q5270109
p:P433
wds:Q51469005-C076D23D-E3C7-499E-AF07-0F41CF72DF83
p:P478
wds:Q51469005-2E600207-F7E1-4D1E-A765-CB854060CC3D
wdt:P433
4
wdt:P478
9
p:P356
wds:Q51469005-F86DA05D-E4C7-4976-9D76-84CE8956E780
wdtn:P356
n11:J.1463-1326.2006.00632.X
wdt:P356
10.1111/J.1463-1326.2006.00632.X